INMODE LTD (INMD)

IL0011595993 - Common Stock

17.37  +0.23 (+1.34%)

After market: 17.37 0 (0%)

Fundamental Rating

7

Overall INMD gets a fundamental rating of 7 out of 10. We evaluated INMD against 195 industry peers in the Health Care Equipment & Supplies industry. INMD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. INMD scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make INMD a good candidate for value and quality investing.



9

1. Profitability

1.1 Basic Checks

In the past year INMD was profitable.
INMD had a positive operating cash flow in the past year.
Each year in the past 5 years INMD has been profitable.
In the past 5 years INMD always reported a positive cash flow from operatings.

1.2 Ratios

INMD has a better Return On Assets (22.92%) than 98.97% of its industry peers.
INMD has a Return On Equity of 25.13%. This is amongst the best in the industry. INMD outperforms 96.92% of its industry peers.
INMD has a better Return On Invested Capital (20.97%) than 98.46% of its industry peers.
The Average Return On Invested Capital over the past 3 years for INMD is significantly above the industry average of 8.50%.
The 3 year average ROIC (28.25%) for INMD is well above the current ROIC(20.97%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 22.92%
ROE 25.13%
ROIC 20.97%
ROA(3y)27.49%
ROA(5y)27.16%
ROE(3y)31.31%
ROE(5y)31.63%
ROIC(3y)28.25%
ROIC(5y)27.22%

1.3 Margins

INMD has a Profit Margin of 40.21%. This is amongst the best in the industry. INMD outperforms 99.49% of its industry peers.
INMD's Profit Margin has improved in the last couple of years.
INMD's Operating Margin of 39.76% is amongst the best of the industry. INMD outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of INMD has grown nicely.
The Gross Margin of INMD (83.59%) is better than 93.85% of its industry peers.
In the last couple of years the Gross Margin of INMD has remained more or less at the same level.
Industry RankSector Rank
OM 39.76%
PM (TTM) 40.21%
GM 83.59%
OM growth 3Y4.03%
OM growth 5Y4.81%
PM growth 3Y3.39%
PM growth 5Y12.47%
GM growth 3Y-0.57%
GM growth 5Y-0.32%

9

2. Health

2.1 Basic Checks

INMD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for INMD has been increased compared to 1 year ago.
INMD has more shares outstanding than it did 5 years ago.
INMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 15.15 indicates that INMD is not in any danger for bankruptcy at the moment.
The Altman-Z score of INMD (15.15) is better than 92.31% of its industry peers.
INMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.15
ROIC/WACC2.33
WACC9.01%

2.3 Liquidity

INMD has a Current Ratio of 13.18. This indicates that INMD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 13.18, INMD belongs to the best of the industry, outperforming 95.90% of the companies in the same industry.
INMD has a Quick Ratio of 12.48. This indicates that INMD is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of INMD (12.48) is better than 95.90% of its industry peers.
Industry RankSector Rank
Current Ratio 13.18
Quick Ratio 12.48

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.35% over the past year.
INMD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 45.76% yearly.
INMD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.34%.
Measured over the past years, INMD shows a very strong growth in Revenue. The Revenue has been growing by 37.48% on average per year.
EPS 1Y (TTM)5.35%
EPS 3Y34.38%
EPS 5Y45.76%
EPS growth Q2Q-8.97%
Revenue 1Y (TTM)8.34%
Revenue growth 3Y33.65%
Revenue growth 5Y37.48%
Revenue growth Q2Q-5.1%

3.2 Future

INMD is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.47% yearly.
The Revenue is expected to grow by 5.67% on average over the next years.
EPS Next Y1.6%
EPS Next 2Y3.76%
EPS Next 3Y4.47%
EPS Next 5YN/A
Revenue Next Year1.73%
Revenue Next 2Y4.78%
Revenue Next 3Y5.67%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

8

4. Valuation

4.1 Price/Earnings Ratio

INMD is valuated cheaply with a Price/Earnings ratio of 6.79.
98.46% of the companies in the same industry are more expensive than INMD, based on the Price/Earnings ratio.
INMD is valuated cheaply when we compare the Price/Earnings ratio to 25.20, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 6.68, the valuation of INMD can be described as very cheap.
Based on the Price/Forward Earnings ratio, INMD is valued cheaper than 98.97% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.60. INMD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.79
Fwd PE 6.68

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INMD indicates a rather cheap valuation: INMD is cheaper than 98.97% of the companies listed in the same industry.
INMD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INMD is cheaper than 98.97% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.35
EV/EBITDA 1.81

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
INMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4.24
PEG (5Y)0.15
EPS Next 2Y3.76%
EPS Next 3Y4.47%

0

5. Dividend

5.1 Amount

No dividends for INMD!.
Industry RankSector Rank
Dividend Yield N/A

INMODE LTD

NASDAQ:INMD (4/23/2024, 7:06:08 PM)

After market: 17.37 0 (0%)

17.37

+0.23 (+1.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.47B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 6.79
Fwd PE 6.68
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)4.24
PEG (5Y)0.15
Profitability
Industry RankSector Rank
ROA 22.92%
ROE 25.13%
ROCE
ROIC
ROICexc
ROICexgc
OM 39.76%
PM (TTM) 40.21%
GM 83.59%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 13.18
Quick Ratio 12.48
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)5.35%
EPS 3Y34.38%
EPS 5Y
EPS growth Q2Q
EPS Next Y1.6%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)8.34%
Revenue growth 3Y33.65%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y